Brief: MaxCyte Q1 Revenue USD 8.2 Million Vs. IBES Estimate USD 9.06 Million
07/05/2025 21:05
May 07 (Reuters) - MaxCyte Q1 operating expenses USD 21.2 million. Q1 cash & investments USD 174.7 million Q1 gross profit USD 8.9 million Q1 adjusted EBITDA USD -11.2 million Q1 net income USD -10.3 million
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview